#Ramji S, Daniel S, Ansari A, et al. Tobacco smoking is not associated with primary open-angle glaucoma: a systematic review and meta-analysis. Int Ophthalmol. 2026;46(1):96. 2. Prates SKP, Barros MEB, Franco JBM, et al. Primary open-angle glaucoma. International Health Sciences Review. 2025;1(3):44-51. 3. Shukla AG, Cioffi GA, John SW, et al. American Glaucoma Society-American Academy of Ophthalmology position statement on nicotinamide use for glaucoma neuroprotection. Ophthalmol Glaucoma. 2025;8(2):112-116. 4. Boland MV, Giaconi JA, Lee RK, et al. Basic and clinical science course, section 10: glaucoma. San Francisco: American Academy of Ophthalmology; 2024. 5. Salmon JF. Kanski’s clinical ophthalmology, a systematic approach. 10th ed. Philadelphia: Elsevier; 2024. 6. Liu MX, Zhou M, Li DL, et al. Corneal biomechanics in primary open angle glaucoma and ocular hypertension: a systematic review and metaanalysis. J Glaucoma. 2023;32(3):e24-32. 7. Gedde SJ, Vinod K, Wright MM, et al. American Academy of Ophthalmology Preferred Practice Pattern Glaucoma Panel. Primary Open-Angle Glaucoma Preferred Practice Pattern®. Ophthalmology. 2021;128(1):P71-150. 8. European Glaucoma Society. Terminology and guidelines for glaucoma, 5th ed. Br J Ophthalmol. 2021;105(Suppl 1):1-169. 9. Gazzard G, Konstantakopoulou E, Garway-Heath D, et al.; LiGHT Trial Study Group. Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial. Lancet. 2019;393(10180):1505-1516. 10. Allingham RR, Damji KF, Freedman S, et al. Shields textbook of glaucoma. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2014. 11. Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311(18):1901-1911. 12. Yanoff M, Duker JS, Augsburger JJ. Ophthalmology. Edinburgh: Mosby Elsevier; 2009. 13. Ehlers JP, Shah CP. Manual